TIAA CREF Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-165,731
Closed -$4.74M – 3036
2018
Q4
$4.74M Sell
165,731
-6,323
-4% -$180K ﹤0.01% 1420
2018
Q3
$4.8M Sell
172,054
-11,980
-7% -$337K ﹤0.01% 1595
2018
Q2
$5.13M Sell
184,034
-53,960
-23% -$1.45M ﹤0.01% 1579
2018
Q1
$5.92M Buy
237,994
+1,714
+0.7% +$41.7K ﹤0.01% 1451
2017
Q4
$5.72M Sell
236,280
-14,375
-6% -$379K ﹤0.01% 1527
2017
Q3
$6.92M Buy
250,655
+34,867
+16% +$930K ﹤0.01% 1418
2017
Q2
$5.41M Buy
215,788
+2,129
+1% +$52.7K ﹤0.01% 1553
2017
Q1
$5.73M Sell
213,659
-9,626
-4% -$266K ﹤0.01% 1506
2016
Q4
$5.85M Sell
223,285
-11,587
-5% -$287K ﹤0.01% 1494
2016
Q3
$5.87M Sell
234,872
-4,276
-2% -$99.7K ﹤0.01% 1497
2016
Q2
$5.18M Sell
239,148
-1,715
-0.7% -$30.6K ﹤0.01% 1512
2016
Q1
$3.61M Sell
240,863
-4,464
-2% -$74.8K ﹤0.01% 1722
2015
Q4
$5.38M Buy
245,327
+14,935
+6% +$278K ﹤0.01% 1509
2015
Q3
$3.63M Sell
230,392
-9,019
-4% -$145K ﹤0.01% 1755
2015
Q2
$3.42M Buy
239,411
+26,746
+13% +$453K ﹤0.01% 1951
2015
Q1
$3.68M Sell
212,665
-6,856
-3% -$121K ﹤0.01% 1846
2014
Q4
$3.94M Sell
219,521
-11,684
-5% -$188K ﹤0.01% 1794
2014
Q3
$3.04M Sell
231,205
-3,297
-1% -$44.4K ﹤0.01% 1945
2014
Q2
$3.37M Buy
234,502
+3,423
+1% +$44.7K ﹤0.01% 1961
2014
Q1
$2.94M Sell
231,079
-12,388
-5% -$162K ﹤0.01% 2003
2013
Q4
$2.44M Sell
243,467
-736
-0.3% -$8.35K ﹤0.01% 2129
2013
Q3
$3.21M Sell
244,203
-865
-0.4% -$11.3K ﹤0.01% 1909
2013
Q2
$3.5M Buy
+245,068
New +$3.08M ﹤0.01% 1778

Other funds holding NXTM

TIAA CREF Investment Management's NXTM Position: Q1 2019 in Review

TIAA CREF Investment Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 165,731 shares — an estimated $4.74M sold.

TIAA CREF Investment Management first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $6.92M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • TIAA CREF Investment Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • TIAA CREF Investment Management sold 165,731 NxStage Medical Inc. shares in Q1 2019, an estimated $4.74M.
  • TIAA CREF Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • TIAA CREF Investment Management's NxStage Medical Inc. position peaked at $6.92M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.